The association among uric acid, microalbumin and estimated glomerular filtration rate in hypertensive patients: a case control study

Table 2 The multivariate linear regression analysis of Log 24 h-MAU and eGFR

Variates	Log 24 h-MAU					Variates	eGFR
	B	SE	β	t	P	Variates	B	SE	β	t	P
UA (every increased 10 μmol/L)	0.007	0.002	0.163	3.549	< 0.001	UA (every increased 10 μmol/L)	− 0.573	0.126	− 0.196	− 4.531	< 0.001
Duration of hypertension						Age	− 0.796	0.106	− 0.310	− 7.522	< 0.001
Less than 1 year	Reference					Gender (male)	15.316	3.167	0.226	4.836	< 0.001
1–5 years	0.057	0.047	0.062	1.198	0.232	ACEI/ARB intake	− 6.157	2.301	− 0.102	− 2.676	0.008
5–10 years	0.170	0.061	0.141	2.786	0.006	RBC	− 6.972	2.905	− 0.105	− 2.400	0.017
More than 10 years	0.089	0.062	0.073	1.432	0.153	Log 24 h-MAU	− 5.136	2.392	− 0.081	− 2.147	0.032
Grade 3 hypertension	0.131	0.043	0.144	3.052	0.002
Fasting glucose	0.087	0.027	0.147	3.176	0.002

24 h-MAU: 24-h microalbuminuria; eGFR: estimated glomerular filtration rate; UA: uric acid; ACEI/ARB: angiotensin-converting enzyme inhibitor/angiotensin receptor inhibitor; RBC: red blood cell

ISSN: 1471-2261